Skip to main content
. 2018 May 22;8:7980. doi: 10.1038/s41598-018-26306-7

Figure 4.

Figure 4

Drug-candidate properties of sulphated (S)-reticulines. (a) The Alzheimer’s disease-related biomarker intercellular adhesion molecule-1 (ICAM1) expression in the bronchial disease model BF4T treated with (S)-reticuline 7-O-sulphate. (b) A biomarker, tissue inhibitor of metalloproteinase (TIMP1), involving a non-steroidal anti-inflammatory drug in the fibrosis disease model MyoF treated with (S)-reticuline 3′-O-sulphate.